BlackRock
PLSE icon

BlackRock’s Pulse Biosciences PLSE Stock Holding History

BlackRock’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.9M Sell
1,339,778
-17,215
-1% -$318K ﹤0.01% 2848
2025
Q4 		$18.6M Buy
1,356,993
+49,078
+4% +$765K ﹤0.01% 3140
2025
Q3 		$23.2M Sell
1,307,915
-36,357
-3% -$575K ﹤0.01% 3005
2025
Q2 		$20.3M Sell
1,344,272
-4,344
-0.3% -$72.1K ﹤0.01% 3015
2025
Q1 		$21.7M Sell
1,348,616
-21,222
-2% -$396K ﹤0.01% 2879
2024
Q4 		$23.8M Buy
1,369,838
+22,153
+2% +$391K ﹤0.01% 2931
2024
Q3 		$23.6M Buy
1,347,685
+200,812
+18% +$3.42M ﹤0.01% 2923
2024
Q2 		$12.8M Buy
1,146,873
+102,065
+10% +$961K ﹤0.01% 3234
2024
Q1 		$9.1M Sell
1,044,808
-26,928
-3% -$248K ﹤0.01% 3392
2023
Q4 		$13.1M Buy
1,071,736
+105,307
+11% +$729K ﹤0.01% 3252
2023
Q3 		$3.89M Buy
966,429
+44,737
+5% +$278K ﹤0.01% 3760
2023
Q2 		$6.63M Buy
921,692
+696,871
+310% +$4.45M ﹤0.01% 3599
2023
Q1 		$755K Buy
224,821
+1,122
+0.5% +$3.38K ﹤0.01% 4422
2022
Q4 		$620K Buy
223,699
+748
+0.3% +$1.68K ﹤0.01% 4550
2022
Q3 		$513K Sell
222,951
-935
-0.4% -$1.52K ﹤0.01% 4718
2022
Q2 		$343K Sell
223,886
-618,485
-73% -$1.55M ﹤0.01% 4881
2022
Q1 		$4.09M Sell
842,371
-10,755
-1% -$88K ﹤0.01% 4073
2021
Q4 		$12.6M Buy
853,126
+10,574
+1% +$211K ﹤0.01% 3528
2021
Q3 		$18.2M Sell
842,552
-40,144
-5% -$864K ﹤0.01% 3349
2021
Q2 		$14.5M Sell
882,696
-67,603
-7% -$1.29M ﹤0.01% 3483
2021
Q1 		$22.5M Buy
950,299
+67,501
+8% +$2.02M ﹤0.01% 3121
2020
Q4 		$21.1M Sell
882,798
-4,440
-0.5% -$70.6K ﹤0.01% 2982
2020
Q3 		$10.5M Sell
887,238
-6,483
-0.7% -$69.8K ﹤0.01% 3201
2020
Q2 		$9.35M Buy
893,721
+145,937
+20% +$1.31M ﹤0.01% 3215
2020
Q1 		$5.35M Sell
747,784
-10,458
-1% -$109K ﹤0.01% 3327
2019
Q4 		$10.2M Buy
758,242
+3,466
+0.5% +$49.4K ﹤0.01% 3243
2019
Q3 		$11.7M Buy
754,776
+20,210
+3% +$262K ﹤0.01% 3131
2019
Q2 		$9.7M Buy
734,566
+108,059
+17% +$1.47M ﹤0.01% 3270
2019
Q1 		$11M Buy
626,507
+13,434
+2% +$211K ﹤0.01% 3070
2018
Q4 		$7.03M Sell
613,073
-3,085
-0.5% -$37.3K ﹤0.01% 3259
2018
Q3 		$8.74M Buy
616,158
+16,049
+3% +$228K ﹤0.01% 3288
2018
Q2 		$9.09M Buy
600,109
+112,061
+23% +$1.9M ﹤0.01% 3277
2018
Q1 		$6.6M Sell
488,048
-5,498
-1% -$104K ﹤0.01% 3299
2017
Q4 		$11.6M Sell
493,546
-3,514
-0.7% -$82.9K ﹤0.01% 3071
2017
Q3 		$9.25M Buy
497,060
+41,601
+9% +$945K ﹤0.01% 3207
2017
Q2 		$15.7M Buy
455,459
+440,057
+2,857% +$12.1M ﹤0.01% 2907
2017
Q1 		$314K Buy
+15,402
New +$210K ﹤0.01% 4094

Other funds holding PLSE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock's PLSE Position: Q1 2026 in Review

BlackRock reduced its Pulse Biosciences (PLSE) stake by 1.3% in Q1 2026, selling an estimated $318K and leaving 1,339,778 shares worth $28.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

BlackRock first reported a position in PLSE in Q1 2017 and has held it in 37 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • BlackRock held 1,339,778 shares of Pulse Biosciences worth $28.9M as of Q1 2026.
  • BlackRock sold 17,215 Pulse Biosciences shares in Q1 2026, an estimated $318K.
  • Pulse Biosciences made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2848 holding.
  • BlackRock first reported a position in Pulse Biosciences in Q1 2017 and has held it in 37 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.